We further divided the glioma patients from Yancheng Clinical College of Xuzhou Medical University into the C5aR1 high- and low-expression groups and analyzed the correlations between the C5aR1 expression level and the clinicopathological parameters of the glioma patients. This evidence concerns the gene C5AR1 and central nervous system cancer.